CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

MMWRs by subject

Treatment

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

PDF
Tuberculosis Control Activities After Hurricane Katrina - New Orleans, Louisiana, 2005 — MMWR 2006; 55 (No. 12)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5512a2.htm
PDF
Mycobacterium tuberculosis Transmission in a Newborn Nursery and Maternity Ward — New York City, 2003 — MMWR 2005; 54 (No. RR-50, 1280-1283)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5450a2.htm
PDF

Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC — MMWR 2005; 54 (No. RR-15, 1-37)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a1.htm

PDF
MMWR: Errata: Treatment of Tuberculosis (Vol. 52, No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5351a5.htm
PDF

Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents - MMWR 2004; 53 (RR15)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm

PDF

Treating Opportunistic Infections Among HIV-Exposed and Infected Children - MMWR 2004; 53 (RR14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm

PDF
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor - Alpha - California, 2002–2003 - MMWR 2004; 53 (No. 30)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a4.htm
PDF
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2004; 53 (No. 2)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5302a6.htm
PDF

Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection. MMWR 2003; 52 (No. 31).
www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm

PDF
Treatment of Tuberculosis MMWR 2003; 52 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
PDF
 

Errata: Treatment of Tuberculosis - MMWR 2005; 52 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5351a5.htm

PDF
Transmission of Mycobacterium Tuberculosis Associated with Failed Completion of Treatment for Latent Tuberculosis Infection - Chickasaw County, Mississippi, June 1999-March 2002
www.cdc.gov/mmwr/preview/mmwrhtml/mm5211a3.htm
PDF
Tuberculosis Treatment Interruptions ---Ivanovo Oblast, Russian Federation, 1999 - MMWR 2001; 50 (No. 11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5011a2.htm
PDF
Evaluation of a Directly Observed Therapy Short-Course Strategy for Treating Tuberculosis --- Orel Oblast, Russian Federation, 1999--2000 - MMWR 2001; 50 (No. 11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5011a3.htm
PDF

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection - MMWR 2000; 49 (No. RR-6)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm

Updates

PDF
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2000; 49 (No. 9)
www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm
PDF
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations - MMWR 1998; 47 (No. RR-20)
www.cdc.gov/mmwr/preview/mmwrhtml/00055357.htm
PDF
Notice to Readers Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons - MMWR 1998; 47 (No. 42)
www.cdc.gov/mmwr/preview/mmwrhtml/00055516.htm
PDF
Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin. - MMWR 1996; 45 (No. 42)
www.cdc.gov/mmwr/preview/mmwrhtml/00044186.htm
PDF
Severe Isoniazid-Associated Hepatitis New York, 19911993. - MMWR 1993; 42 (No. 28)
www.cdc.gov/mmwr/preview/mmwrhtml/00021200.htm
PDF
Improving Adherence to Antituberculosis Therapy - South Carolina and New York. - MMWR 1993; 42 (No. 4)
www.cdc.gov/mmwr/preview/mmwrhtml/00019521.htm
PDF

 

Archived Treatment

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

MMWR: Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection
www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a4.htm
PDF
Treatment of Tuberculosis and Tuberculosis Infection - Am J Respir Crit Care Med 1994; 149
PDF
Management of Persons Exposed to Multidrug-Resistant Tuberculosis. - MMWR 1992; 41 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00031296.htm
PDF

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333